-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-09-09
HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) provides enzyme-based detection of mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It is suitable for validated immunodetection workflows, but optimal dilution, incubation conditions, cross-reactivity, and assay sensitivity should be established experimentally rather than assumed from the product description.
-
CDK9 inhibitor (A3294): Workflow Guide
2026-09-09
CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for investigating CDK9-linked transcription elongation and HIV-1 propagation inhibition. It is appropriate for focused biochemical and cell-based workflows, but not for pan-CDK studies, unvalidated claims of cellular potency, or long-term storage of prepared solutions.
-
Computational Hapten Design for Mushroom Toxin Detection
2026-09-08
The reference study combines molecular similarity analysis, quantum chemical calculations, and rational hapten design to develop antibodies that recognize amatoxins and phallotoxins with high sensitivity and improved uniformity. Its dual-target fluorescent immunochromatographic assay enables rapid simultaneous screening of both toxin classes in mushroom samples, addressing a major limitation of assays that detect amatoxins alone.
-
Metabolomics Reveals Carbapenemase Resistance
2026-09-07
A 2025 study used LC-MS/MS metabolomics and supervised machine learning to distinguish carbapenemase-producing Enterobacterales from non-producing isolates without antibiotic exposure. Its metabolite signatures provide both a potential rapid diagnostic route and a systems-level view of the metabolic changes associated with carbapenem resistance.
-
How Cancer Persister Cells Resist Direct T Cell Attack
2026-09-07
A 2025 bioRxiv preprint identifies antigenic cancer persister cells that survive sustained cytotoxic T lymphocyte attack rather than avoiding immune recognition. The study links this phenotype to caspase-associated suppression of inflammatory death and later outgrowth of CTL-resistant cells, providing a framework for studying residual disease after immunotherapy.
-
Lovastatin: From Pathway Inhibition to Translation
2026-09-05
Lovastatin is more than a cholesterol biosynthesis inhibitor: it is a mechanistic probe for connecting mevalonate depletion with proliferation, apoptosis, tissue remodeling, and macrophage function. This article presents a pathway-first strategy for using Lovastatin in translational research while clarifying assay boundaries, cross-domain insights, and the limitations of interpreting pleiotropic phenotypes.
-
Ferrostatin-1 (Fer-1) in Reliable Ferroptosis Assays
2026-09-04
Learn how Ferrostatin-1 (Fer-1), SKU A4371, can function as a mechanistic rescue control when viability assays suggest iron-dependent lipid damage. This scenario-based guide covers assay design, solvent handling, interpretation, and practical product-selection criteria for reproducible ferroptosis research.
-
X-Gal (A2539): Reliable β-Galactosidase Assays
2026-09-04
Learn how X-Gal (SKU A2539) supports blue-white colony screening and β-galactosidase reporter workflows while avoiding common interpretation errors in viability and cytotoxicity studies. This scenario-based guide covers assay compatibility, solvent selection, storage, controls, data interpretation, and practical product-selection criteria.
-
Palonosetron Hydrochloride in Cell Assays
2026-09-03
Learn how Palonosetron hydrochloride (SKU B2229) can be used as a defined 5-HT3 receptor antagonist and transporter probe in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers concentration selection, subtype-specific interpretation, solution handling, and supplier reliability using published quantitative data.
-
U 46619: From TP Signaling to Renal Translation
2026-09-03
U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is more than a platelet assay reagent. Its concentration-dependent TP-receptor activity provides a strategic framework for connecting platelet activation, vascular tone, renal hemodynamics, and emerging ischemia-reperfusion biology while keeping established evidence distinct from testable hypotheses.
-
MAPK10–KRT16 Axis in NSCLC Metastasis
2026-09-02
A 2026 study identifies MAPK10 as a metastasis-suppressive kinase that phosphorylates KRT16 at Ser356 and Ser397, enabling RNF213-mediated ubiquitination and proteasomal degradation. The findings connect kinase activity with cytoskeletal protein turnover and suggest a prognostic MAPK10/KRT16/RNF213 axis, while also defining important limits for therapeutic translation.
-
Rotigotine and Antidepressant-Like Effects in Rats
2026-09-02
The 2006 reference study evaluated rotigotine across anxiety, behavioral despair, learned helplessness, and olfactory bulbectomy models, showing antidepressant-like activity at doses that did not consistently increase baseline locomotion. Its main contribution is a dose- and paradigm-sensitive framework for separating potential mood-related effects from nonspecific motor stimulation, which remains relevant to dopaminergic signaling research and Parkinson’s disease research.
-
Camostat Mesilate: From ENaC to Fibrosis
2026-09-01
Camostat Mesilate is a trypsin-like protease inhibitor with a distinctive research profile spanning ENaC function, plasmin activity, TGF-β signaling, and hepatic fibrosis. This guide translates those mechanisms into a layered assay strategy and compares it with structure-guided proteomimetic design.
-
Ginsenosides and PHD2/HIF-1α Signaling in Hypoxia
2026-09-01
This study tests whether ginsenosides protect lung and kidney tissue during simulated high-altitude hypoxia and links the phenotype to PHD2/HIF-1α/EPO signaling. Its integrated physiological, histological, inflammatory, oxidative-stress, and protein-expression readouts provide a useful framework for evaluating tissue protection while leaving causal and translational questions open.
-
Pioglitazone: PPARγ Agonist Research Workflows
2026-08-31
Translate selective PPARγ activation into reproducible macrophage, beta-cell, metabolic, and neuroinflammation assays. This practical guide combines reference-backed DSS intestinal inflammation findings with formulation, controls, readout, and troubleshooting strategies for Pioglitazone research.